{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T10:34:33Z","timestamp":1794825273279,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16066-3","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:05:51Z","timestamp":1776823551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic transcriptomic analysis of UDP-glucuronosyltransferases reveals UGT2B11 as a diagnostic and metabolic marker in hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Hyun Sun","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geum Ok","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Gyeong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Ha","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Youn","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Woo","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"16066_CR1","doi-asserted-by":"crossref","unstructured":"Chakraborty E, Sarkar DJC. Emerging therapies for Hepatocellular Carcinoma (HCC). Cancers (Basel). 2022;14(11):2798.","DOI":"10.3390\/cancers14112798"},{"key":"16066_CR2","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","DOI":"10.3322\/caac.21834"},{"key":"16066_CR3","doi-asserted-by":"crossref","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB. Sarkar DJAicr. Hepatocellular Carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1\u201361.","DOI":"10.1016\/bs.acr.2020.10.001"},{"key":"16066_CR4","doi-asserted-by":"crossref","unstructured":"Waller LP, Deshpande V, Pyrsopoulos NJW. Hepatocellular carcinoma: a comprehensive review. World J Hepatol. 2015;7(26):2648.","DOI":"10.4254\/wjh.v7.i26.2648"},{"key":"16066_CR5","doi-asserted-by":"crossref","unstructured":"Wang Y, Deng BJC, Reviews M. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42(3):629\u201352.","DOI":"10.1007\/s10555-023-10084-4"},{"key":"16066_CR6","doi-asserted-by":"crossref","unstructured":"Akabane M, Imaoka Y, Kawashima J, Pawlik TMJHO. Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy. Hepat Oncol. 2025;12(1):2493457.","DOI":"10.1080\/20450923.2025.2493457"},{"key":"16066_CR7","doi-asserted-by":"crossref","unstructured":"Yu J, Park R, Kim RJJHC. Promising novel biomarkers for hepatocellular carcinoma: diagnostic and prognostic insights. J Hepatocell Carcinoma. 2023:1105\u201327.","DOI":"10.2147\/JHC.S341195"},{"key":"16066_CR8","doi-asserted-by":"crossref","unstructured":"Gao B, Lu Y, Lai X, Xu X, Gou S, Yang Z et al. Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications. Front Immunol. 2025;16:1592837.","DOI":"10.3389\/fimmu.2025.1592837"},{"key":"16066_CR9","doi-asserted-by":"crossref","unstructured":"Liao D-X, An X, Huang G-X, Yuan T-LJFI. The impact of metabolic reprogramming in hepatocellular carcinoma on T cell. Front Immunol. 2025;16:1696113.","DOI":"10.3389\/fimmu.2025.1696113"},{"key":"16066_CR10","doi-asserted-by":"crossref","unstructured":"Vishnoi K, Kumar S, Ke R, Rana A, Rana BJC. Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming. Curr Opin Pharmacol. 2022;64:102232.","DOI":"10.1016\/j.coph.2022.102232"},{"key":"16066_CR11","doi-asserted-by":"crossref","unstructured":"Wang X, Cui Q, Zhou YJB. Nucleotide Metabolism and Immune Genes Can Predict the Prognostic Risk of Hepatocellular Carcinoma and the Immune Microenvironment. Biomedicines. 2025;14(8):1079.","DOI":"10.3390\/biology14081079"},{"key":"16066_CR12","doi-asserted-by":"crossref","unstructured":"Allain EP, Rouleau M, L\u00e9vesque E, Guillemette CJB. Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression. Br J Cancer. 2020;122(9):1277\u201387.","DOI":"10.1038\/s41416-019-0722-0"},{"issue":"3","key":"16066_CR13","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00204-024-03929-6","volume":"99","author":"J Xue","year":"2025","unstructured":"Xue J, Li Q, Wang Y, Yin R, Zhang J. Insight into the structure, oligomerization, and the role in drug resistance of human UDP-glucuronosyltransferases. Arch Toxicol. 2025;99(3):1153\u201365.","journal-title":"Arch Toxicol"},{"key":"16066_CR14","doi-asserted-by":"crossref","unstructured":"Yang F, Liu S, Wolber G, Bureik M, Parr MKJI. Complete reaction phenotyping of propranolol and 4-hydroxypropranolol with the 19 enzymes of the human UGT1 and UGT2 families. Int J Mol Sci. 2022;23(13):7476.","DOI":"10.3390\/ijms23137476"},{"issue":"6","key":"16066_CR15","doi-asserted-by":"publisher","first-page":"e01154","DOI":"10.1002\/prp2.1154","volume":"11","author":"L Zhou","year":"2023","unstructured":"Zhou L, Montalvo AD, Collins JM, Wang D. Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues. Pharmacol Res Perspect. 2023;11(6):e01154.","journal-title":"Pharmacol Res Perspect"},{"key":"16066_CR16","doi-asserted-by":"crossref","unstructured":"Hu DG, Marri S, Mackenzie PI, Hulin J-A, McKinnon RA, Meech RJC. The expression profiles and deregulation of UDP-glycosyltransferase (UGT) genes in human cancers and their association with clinical outcomes. Cancers (Basel). 2021;13(17):4491.","DOI":"10.3390\/cancers13174491"},{"key":"16066_CR17","doi-asserted-by":"crossref","unstructured":"Meech R, Hu DG, McKinnon RA, Mubarokah SN, Haines AZ, Nair PC et al. The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms. Physiol Rev. 2019;99(2):1153\u2013222.","DOI":"10.1152\/physrev.00058.2017"},{"key":"16066_CR18","doi-asserted-by":"crossref","unstructured":"Liu W, Li J, Zhao R, Lu Y, Huang PJFO. The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism. Front Oncol. 2023;12:1088458.","DOI":"10.3389\/fonc.2022.1088458"},{"issue":"1","key":"16066_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1186\/s12885-024-12712-w","volume":"24","author":"R Liu","year":"2024","unstructured":"Liu R, Yang T, Huang J, Xiao Z, Liu J, Li Z, et al. Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer. BMC Cancer. 2024;24(1):947.","journal-title":"BMC Cancer"},{"key":"16066_CR20","doi-asserted-by":"crossref","unstructured":"Cho C-S, Kowalsky AH, Lee JHJG. Pathological consequences of hepatic mTORC1 dysregulation. Genes (Basel). 2020;11(8):896.","DOI":"10.3390\/genes11080896"},{"key":"16066_CR21","doi-asserted-by":"crossref","unstructured":"Liu H-J, Du H, Khabibullin D, Zarei M, Wei K, Freeman GJ et al. mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion. Nat Commun. 2023;14(1):1214.","DOI":"10.1038\/s41467-023-36881-7"},{"key":"16066_CR22","doi-asserted-by":"crossref","unstructured":"Bai Y, Chen D, Cheng C, Li Z, Chi H, Zhang Y et al. Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing. Front Immunol. 2022;13:950536.","DOI":"10.3389\/fimmu.2022.950536"},{"key":"16066_CR23","doi-asserted-by":"crossref","unstructured":"Cisneros-Villanueva M, Fonseca-Monta\u00f1o MA, R\u00edos-Romero M, L\u00f3pez-Camarillo C, Jim\u00e9nez-Morales S, Langley E et al. LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer. Sci Rep. 2024;14(1):1483.","DOI":"10.1038\/s41598-024-51947-2"},{"key":"16066_CR24","doi-asserted-by":"crossref","unstructured":"Wu Z, Liu Z, Wang Y, Teng G, Li X, Lu T et al. A comprehensive analysis of the tryptophan metabolism-related gene signature to predict the prognosis of esophageal squamous cell carcinoma based on multi-omics. Front Mol Biosci. 2025;12:1613539.","DOI":"10.3389\/fmolb.2025.1613539"},{"issue":"03","key":"16066_CR25","doi-asserted-by":"publisher","first-page":"2530004","DOI":"10.1142\/S1793545825300046","volume":"18","author":"X Men","year":"2025","unstructured":"Men X, Liu F, Gong M, Wang X, Wang L, Men X, et al. Activatable fluorescent probes for imaging and diagnosis of hepatocellular carcinoma. J Innovative Opt Health Sci. 2025;18(03):2530004.","journal-title":"J Innovative Opt Health Sci"},{"issue":"5","key":"16066_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3892\/ol.2021.13052","volume":"22","author":"HR Ahn","year":"2021","unstructured":"Ahn HR, Baek GO, Yoon MG, Son JA, You D, Yoon JH, et al. HMBS is the most suitable reference gene for RT-qPCR in human HCC tissues and blood samples.Oncology Letters. Oncol Lett. 2021;22(5):791.","journal-title":"Oncol Lett"},{"key":"16066_CR27","doi-asserted-by":"crossref","unstructured":"Kurzawski M, Szel\u0105g-Pieniek S, \u0141apczuk-Roma\u0144ska J, Wrzesi\u0144ski M, Oswald S, Dro\u017adzik MJPR. The reference liver\u2014CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype. Pharmacol Rep. 2022;74(1):204\u201315.","DOI":"10.1007\/s43440-021-00337-w"},{"issue":"2","key":"16066_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/cancers16020353","volume":"16","author":"DG Hu","year":"2024","unstructured":"Hu DG, Marri S, Hulin J-A, McKinnon RA, Mackenzie PI, Meech R. A Comprehensive Bioinformatic Analysis of RNA-seq Datasets Reveals a Differential and Variable Expression of Wildtype and Variant UGT1A Transcripts in Human Tissues and Their Deregulation in Cancers. Cancers. 2024;16(2):353.","journal-title":"Cancers"},{"issue":"8","key":"16066_CR29","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/1878-0261.13659","volume":"18","author":"YC Pan","year":"2024","unstructured":"Pan YC, Chu PY, Lin CC, Hsieh CY, Hsu WY, Shyur LF, et al. Glutathione S-transferase omega class 1 (GSTO1)\u2010associated large extracellular vesicles are involved in tumor\u2010associated macrophage\u2010mediated cisplatin resistance in bladder cancer. Mol Oncol. 2024;18(8):1866\u201384.","journal-title":"Mol Oncol"},{"key":"16066_CR30","doi-asserted-by":"crossref","unstructured":"Lazarus P, Blevins-Primeau AS, Zheng Y, Sun DJANYAS. Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen. Ann N Y Acad Sci. 2009;1155(1):99\u2013111.","DOI":"10.1111\/j.1749-6632.2009.04114.x"},{"key":"16066_CR31","doi-asserted-by":"crossref","unstructured":"Torrence ME, MacArthur MR, Hosios AM, Valvezan AJ, Asara JM, Mitchell JR et al. The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals. Elife. 2021;10:e63326.","DOI":"10.7554\/eLife.63326"},{"key":"16066_CR32","doi-asserted-by":"crossref","unstructured":"D\u00fcvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010;39(2):171\u201383.","DOI":"10.1016\/j.molcel.2010.06.022"},{"key":"16066_CR33","doi-asserted-by":"crossref","unstructured":"Huang W-Y, Liao Z-B, Zhang J-C, Zhang X, Zhang H-W, Liang H-F et al. USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt\/mTOR signaling. Cell Death Dis. 2022;13(11):917.","DOI":"10.1038\/s41419-022-05363-x"},{"key":"16066_CR34","doi-asserted-by":"crossref","unstructured":"Li L, Yang L, Fan Z, Xue W, Shen Z, Yuan Y et al. Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma. Signal Transduct Target Ther. 2020;5(1):54.","DOI":"10.1038\/s41392-020-0152-8"},{"key":"16066_CR35","doi-asserted-by":"crossref","unstructured":"Moralev AD, Markov OV, Zenkova MA, Markov AVJB. Novel cross-cancer hub genes in doxorubicin resistance identified by transcriptional mapping. Biomedicines. 2025;13(10):2527.","DOI":"10.3390\/biomedicines13102527"},{"key":"16066_CR36","doi-asserted-by":"crossref","unstructured":"Zheng C, Zheng L, Yoo J-K, Guo H, Zhang Y, Guo X et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169(7):1342\u201356. e16.","DOI":"10.1016\/j.cell.2017.05.035"},{"key":"16066_CR37","doi-asserted-by":"crossref","unstructured":"Lin J, Rao D, Zhang M, Gao, QJJoh, editors. oncology. Metabolic reprogramming in the tumor microenvironment of liver cancer. J Hematol Oncol. 2024;17(1):6.","DOI":"10.1186\/s13045-024-01527-8"},{"key":"16066_CR38","doi-asserted-by":"crossref","unstructured":"Zeng H, Yang K, Cloer C, Neale G, Vogel P, Chi HJN. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature. 2013;499(7459):485\u201390.","DOI":"10.1038\/nature12297"},{"issue":"4","key":"16066_CR39","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.36922\/cp.1917","volume":"5","author":"H Yang","year":"2023","unstructured":"Yang H, Jiang Q. A spatial transcriptome-based perspective on highly variable genes associated with the tumor microenvironment in hepatocellular carcinoma. Cancer Plus. 2023;5(4):1917.","journal-title":"Cancer Plus"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16066-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:46:32Z","timestamp":1780620392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16066-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16066"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16066-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Ajou University Hospital (AJOUIRB-EX-2022-389 and AJOUIRB-EX-2024-332), corresponding to distinct sample and data collection periods. The requirement for informed consent was waived because all samples and clinical data were anonymized prior to analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"709"}}